Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/10/1999 | WO1999029890A3 Assessment of human papilloma virus-related disease |
09/10/1999 | WO1999028489A9 Cell-specific retroviral vectors with antibody domains and method for the production thereof for selective gene transfer |
09/10/1999 | WO1999028466A9 Compositions and methods of use of het |
09/10/1999 | WO1999028463A3 Methods for the degradation and detoxification of organic material using urine produced by transgenic animals |
09/10/1999 | WO1999027958A9 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
09/10/1999 | WO1999027102A9 Cd4+ t-lymphocyte protease genes and inhibitors thereof |
09/10/1999 | WO1999027081A9 Alpha/beta hydrolase-fold enzymes |
09/10/1999 | WO1999025829A3 Cdk2 protein and cdk2 protein complexes |
09/10/1999 | WO1999025819A3 Antisense oligonucleotides against tenascin for treating vitiligo |
09/10/1999 | WO1999025817A9 Tc1-based transposon vectors |
09/10/1999 | WO1999024472A8 Glycosylated antibodies and antibody fragments having reactive ketone groups |
09/10/1999 | WO1999023249A3 Specific and sensitive method for detecting nucleic acids |
09/10/1999 | WO1999021992A3 Nucleic acid molecules encoding a glutamate receptor |
09/10/1999 | WO1999020756A3 Human toll homologues |
09/10/1999 | WO1999020644A9 Secreted proteins and polynucleotides encoding them |
09/10/1999 | WO1999013907A9 Methods to improve immunogenicity of antigens and specificity of antibodies |
09/10/1999 | WO1999010487A9 Novel transcriptional regulators and uses therefor |
09/10/1999 | WO1999001548A3 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
09/10/1999 | WO1998005356A8 NOVEL FtsL |
09/10/1999 | CA2326408A1 Epitope peptides immunogenic against streptococcus pneumoniae |
09/10/1999 | CA2323094A1 Embryonic or stem-like cell lines produced by cross-species nuclear transplantation |
09/10/1999 | CA2322788A1 Tagged ligand arrays for identifying ligand-target interactions |
09/10/1999 | CA2322749A1 Cd147 binding molecules as therapeutics |
09/10/1999 | CA2322731A1 Lectomedin materials and methods |
09/10/1999 | CA2322719A1 Genetic sequences conferring pathogen resistance in plants and uses therefor |
09/10/1999 | CA2322684A1 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
09/10/1999 | CA2322665A1 Delivery of proteins into eukaryotic cells with recombinant yersinia |
09/10/1999 | CA2322664A1 Enhanced prodrug activation |
09/10/1999 | CA2322622A1 Highly crystalline urokinase |
09/10/1999 | CA2322621A1 V-like domain binding molecules |
09/10/1999 | CA2322505A1 Production of mycobacterial polypeptides by lactic acid bacteria |
09/10/1999 | CA2322488A1 A fluorescence polarization screening method |
09/10/1999 | CA2322425A1 Novel fdrg protein and nucleic acid molecules and uses therefor |
09/10/1999 | CA2322382A1 Method for the induction of pathogen resistance in plants |
09/10/1999 | CA2322381A1 Human synapse related glycoproteins (hsrp) |
09/10/1999 | CA2321948A1 Zymogenic nucleic acid detection methods, and related molecules and kits |
09/10/1999 | CA2321931A1 Methods for identifying polycationic, peptide-like compounds with antibacterial activity |
09/10/1999 | CA2321930A1 Production and use of normalized dna libraries |
09/10/1999 | CA2321270A1 Novel calpain and dna encoding the same |
09/10/1999 | CA2321261A1 Baculovirus expression system and method for high throughput expression of genetic material |
09/10/1999 | CA2316612A1 Methods and compositions for regulating cell death and enhancing disease resistance to plant pathogens |
09/10/1999 | CA2249661A1 Novel compounds |
09/10/1999 | CA2249041A1 Novel compounds |
09/09/1999 | DE19808889A1 Vektoren und Viren zur Gentherapie Vectors and viruses for gene therapy |
09/09/1999 | DE19808717A1 Selecting genes that express mutant proteins of high stability, especially enzymes and binding proteins |
09/09/1999 | DE19808192A1 Diisopropylfluorophosphatase sowie deren Verwendung und Herstellung Diisopropyl fluorophosphatase and their use and production |
09/08/1999 | EP0940676A2 Device for treating biomolecules |
09/08/1999 | EP0940469A2 Cloning by complementation and related processes |
09/08/1999 | EP0940468A1 Humanized antibody variable domain |
09/08/1999 | EP0940467A1 Promoters for swine complement inhibitors |
09/08/1999 | EP0940450A1 Energy transfer dyes with enhanced fluorescence |
09/08/1999 | EP0939833A1 USE OF A MUTATION IN THE GENE FOR HUMAN G-PROTEIN beta 3 SUB-UNIT FOR DIAGNOSING ILLNESSES |
09/08/1999 | EP0939832A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus |
09/08/1999 | EP0939830A1 A method of improving the production of biomass or a desired product from a cell |
09/08/1999 | EP0939829A1 Methods of modulating melanin synthesis |
09/08/1999 | EP0939828A1 Herpesvirus saimiri as viral vector |
09/08/1999 | EP0939827A1 Lentiviral vectors |
09/08/1999 | EP0939826A2 Delivery of tolerogenic antigens via edible plants or plant-derived products |
09/08/1999 | EP0939825A1 Truncated cbh i promoter from trichoderma reesei and use thereof |
09/08/1999 | EP0939824A1 Reagents and methods useful for detecting diseases of the breast |
09/08/1999 | EP0939822A2 Use of mutated macrolide binding protein for the prevention of guhd |
09/08/1999 | EP0939821A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
09/08/1999 | EP0939820A1 Nucleic acid sequences that encode a cell growth regulatory protein and uses thereof |
09/08/1999 | EP0939819A1 Mini-e1a genes and gene products |
09/08/1999 | EP0939818A1 Recombinant toxin fragments |
09/08/1999 | EP0939817A2 High-affinity interleukin-4 muteins |
09/08/1999 | EP0939816A1 Circularly permuted erythropoietin receptor agonists |
09/08/1999 | EP0939815A1 IDENTIFICATION OF Bap-1, A PROTEIN THAT BINDS TO INTEGRIN AND IS INVOLVED IN INTEGRIN-MEDIATED SIGNAL TRANSDUCTION |
09/08/1999 | EP0939814A1 Fringe proteins and notch signalling |
09/08/1999 | EP0939813A1 Breast carcinoma-associated gene |
09/08/1999 | EP0939812A2 Novel human macrophage antigen |
09/08/1999 | EP0939811A1 Recombinant plant cells expressing heterochromatin 1 (hp1) of drosophila melanogaster |
09/08/1999 | EP0939810A2 Transcriptional intermediary factor-2 tif2 |
09/08/1999 | EP0939809A2 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
09/08/1999 | EP0939808A1 Spruce budworm antifreeze proteins, genes and methods of using same |
09/08/1999 | EP0939807A2 Secreted proteins and polynucleotides encoding them |
09/08/1999 | EP0939806A1 Fanconi gene 1 |
09/08/1999 | EP0939805A2 Secreted proteins and polynucleotides encoding them |
09/08/1999 | EP0939804A1 NEUTROKINE alpha |
09/08/1999 | EP0939803A1 Production of cartilage tissue using cells isolated from wharton's jelly |
09/08/1999 | EP0939802A1 spsA POLYNUCLEOTIDES AND POLYPEPTIDES |
09/08/1999 | EP0939800A2 HELICOBACTER ANTIGEN (gamma-GLUTAMYLTRANSFERASE) AND SEQUENCES ENCODING THE SAME |
09/08/1999 | EP0939799A1 Enzymatic cofactor cycling using soluble pyridine nucleotide transhydrogenase |
09/08/1999 | EP0939798A2 Antifungal proteins, dna coding therefore, and hosts incorporating same |
09/08/1999 | EP0939770A1 Receptor specific brain natriuretic peptide (bnp) |
09/08/1999 | EP0939769A1 Vertebrate smoothened proteins |
09/08/1999 | EP0939767A1 Modified factor viii |
09/08/1999 | EP0939764A2 Molecular genetic construction of vaccine strains of pasteurellaceae |
09/08/1999 | EP0939763A1 Directed switch-mediated dna recombination |
09/08/1999 | EP0939762A2 Electrodes linked via conductive oligomers to nucleic acids |
09/08/1999 | EP0939653A1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
09/08/1999 | EP0939652A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation |
09/08/1999 | EP0939646A2 Compounds and methods for treatment and diagnosis of mycobacterial infections |
09/08/1999 | EP0939643A1 Immunomodulating compounds comprising d-isomers of amino acids |
09/08/1999 | EP0939642A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
09/08/1999 | EP0939621A1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
09/08/1999 | EP0939590A1 Delivery of therapeutic gene products by intestinal cell expression |
09/08/1999 | EP0927044A4 Targeted viral vectors |
09/08/1999 | EP0889751B1 Device and method for multiple analyte detection |
09/08/1999 | EP0871545A4 Silicon-based sleeve devices for chemical reactions |